ALEXANDRIA, Va., Feb. 26 -- United States Patent no. 12,234,231, issued on Feb. 25, was assigned to PIC Therapeutics Inc. (Natick, Mass.).
"EIF4E inhibitors and uses thereof" was invented by Christopher L. Vandeusen (Hopkinton, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compounds inhibiting eIF4E activity, and compositions and methods of using thereof."
The patent was filed on Aug. 25, 2022, under Application No. 17/822,344.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=12234231&OS=12234231&RS=1223...